Author

admin

Browsing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Stallion Uranium Corp. (the ‘Company’ or ‘Stallion’) (TSX-V: STUD; OTCQB: STLNF; FSE: B76) is pleased to announce that, further to its news releases dated December 12, 2025 and December 17, 2025, it has increased its non-brokered private placement to raise gross proceeds of $7,723,064 (the ‘Offering’). The Company also announces that it has closed the Offering, issuing 17,162,365 flow-through shares of the Company as a ‘flow-through share’ within the meaning of the Income Tax Act (Canada) (each, a ‘FT Share’) at a price of $0.45 per FT Share.

The gross proceeds from the FT Shares will be used by the Company to incur eligible ‘Canadian exploration expenses’ that qualify as ‘flow-through critical mineral mining expenditures’ as such terms are defined in the Income Tax Act (Canada) (the ‘Qualifying Expenditures‘) related to the Company’s uranium projects in the Athabasca Basin, Saskatchewan, on or before December 31, 2026. All Qualifying Expenditures will be renounced in favour of the subscribers of the FT Shares effective December 31, 2025.

The FT Shares issued pursuant to the Offering are subject to a four-month and one day hold period from the date of issuance under applicable Canadian securities laws.

In connection with the closing of the Offering, the Company paid the following cash fees to eligible arm’s length finders: $24,728 to Canaccord Genuity Corp., $353,524.84 to Accilent Capital Management Inc., $3,465 to Research Capital Corporation, $70,000 to PB Markets Inc., $47,250 to GloRes Securities Inc.; $28,000 to Wealth (WCPD Inc.), and $3,150 to Sightline Wealth Management.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any state securities laws and may not be offered or sold within the United States or to or for the account or benefit of a U.S. person (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Stallion Uranium Corp.:

Stallion Uranium is working to ‘Fuel the Future with Uranium’ through the exploration of roughly 1,700 sq/km in the Athabasca Basin, home to the largest high-grade uranium deposits in the world. The company, with JV partner Atha Energy holds the largest contiguous project in the Western Athabasca Basin adjacent to multiple high-grade discovery zones. With a commitment to responsible exploration and cutting-edge technology such as the use of the proprietary Haystack TI technology, Stallion is positioned to play a key role in the future of clean energy.

Our leadership and advisory teams are comprised of uranium and precious metals exploration experts with the capital markets experience and the technical talent for acquiring and exploring early-stage properties. For more information visit stallionuranium.com.

On Behalf of the Board of Stallion Uranium Corp.:

Matthew Schwab
CEO and Director

Corporate Office:
700 – 838 West Hastings Street,
Vancouver, British Columbia,
V6C 0A6

T: 604-551-2360
info@stallionuranium.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, ‘forward-looking statements’) that relate to the Company’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as ‘will likely result’, ‘are expected to’, ‘expects’, ‘will continue’, ‘is anticipated’, ‘anticipates’, ‘believes’, ‘estimated’, ‘intends’, ‘plans’, ‘forecast’, ‘projection’, ‘strategy’, ‘objective’ and ‘outlook’) are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this material change report should not be unduly relied upon. These statements speak only as of the date they are made.

Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond the Company’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for the Company to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements contained in this presentation are expressly qualified in their entirety by this cautionary statement.

News Provided by GlobeNewswire via QuoteMedia

This post appeared first on investingnews.com

The Department of Homeland Security (DHS) is disputing reports that acting Cybersecurity and Infrastructure Security Agency (CISA) Director Madhu Gottumukkala failed a polygraph after seeking access to highly sensitive intelligence, as an internal investigation and the suspension of multiple career cybersecurity officials deepen turmoil inside the agency, according to a report.

Politico reported that Gottumukkala pushed for access to a tightly restricted intelligence program that required a counter-intelligence polygraph and that at least six career staffers were later placed on paid administrative leave for allegedly misleading leadership about the requirement, an assertion DHS strongly denies.

The outlet said its reporting was based on interviews with four former and eight current cybersecurity officials, including multiple Trump administration appointees who worked with Gottumukkala or had knowledge of the polygraph examination and the events that followed. All 12 were granted anonymity over concerns about retaliation, according to Politico.

DHS pushed back on the reporting, saying the polygraph at issue was not authorized and that disciplinary action against career staff complied with department policy.

‘Acting Director Madhu Gottumukkala did not fail a sanctioned polygraph test. An unsanctioned polygraph test was coordinated by staff, misleading incoming CISA leadership,’ DHS Assistant Secretary Tricia McLaughlin said in a statement provided to Fox News Digital. ‘The employees in question were placed on administrative leave, pending conclusion of an investigation.’

‘We expect and require the highest standards of performance from our employees and hold them directly accountable to uphold all policies and procedures,’ she continued. ‘Acting Director Gottumukkala has the complete and full support of the Secretary and is laser focused on returning the agency to its statutory mission.’

Politico also reported that Gottumukkala failed a polygraph during the final week of July, citing five current officials and one former official.

The test was administered to determine whether he would be eligible to review one of the most sensitive intelligence programs shared with CISA by another U.S. spy agency, according to the outlet.

That intelligence was part of a controlled access program with strict distribution limits, and the originating agency required any CISA personnel granted need-to-know access to first pass a counter-intelligence polygraph, according to four current officials and one former official cited by Politico.

As a civilian agency, most CISA employees do not require access to such highly classified material or a polygraph to be hired, though polygraphs are commonly used across the Pentagon and U.S. intelligence community to protect the government’s most sensitive information.

Politico reported that senior staff raised questions on at least two occasions about whether Gottumukkala needed access to the intelligence, but said he continued pressing for it even if it meant taking a polygraph, citing four current officials.

The outlet also reported that an initial access request in early June, signed by mid-level CISA staff, was denied by a senior agency official who determined there was no urgent need-to-know and noted that the agency’s previous deputy director had not viewed the program.

That senior official was later placed on administrative leave for unrelated reasons in late June, and a second access request signed by Gottumukkala was approved in early July after the official was no longer in the role, according to current officials cited by Politico.

Despite being advised that access to the most sensitive material was not essential to his job and that lower-classification alternatives were available, Gottumukkala continued to pursue access, officials told the outlet.

Officials interviewed by Politico said they could not definitively explain why Gottumukkala did not pass the July polygraph and cautioned that failures can occur for innocuous reasons such as anxiety or technical errors, noting that polygraph results are generally not admissible in U.S. courts.

On Aug. 1, shortly after the polygraph, at least six career staff involved in scheduling and approving the test were notified in letters from then–acting DHS Chief Security Officer Michael Boyajian that their access to classified national security information was being temporarily suspended for potentially misleading Gottumukkala, according to officials and a letter reviewed by Politico.

‘This action is being taken due to information received by this office that you may have participated in providing false information to the acting head of the Cybersecurity and Infrastructure Security Agency (CISA) regarding the existence of a requirement for a polygraph examination prior to accessing certain programs,’ the letter said. ‘The above allegation shows deliberate or negligent failure to follow policies that protect government information, which raises concerns regarding an individual’s trustworthiness, judgment, reliability or willingness and ability to safeguard classified information.’

In a separate letter dated Aug. 4, the suspended employees were informed by Acting CISA Chief Human Capital Officer Kevin Diana that they had been placed on paid administrative leave pending an investigation, according to current and former officials and a copy reviewed by Politico.

Gottumukkala was appointed CISA deputy director in May and previously served as commissioner and chief information officer for South Dakota’s Bureau of Information and Technology, which oversees statewide technology and cybersecurity initiatives.

CISA said in a May press release that Gottumukkala has more than two decades of experience in information technology and cybersecurity across the public and private sectors.

This post appeared first on FOX NEWS

The U.S. Department of Justice (DOJ) said Sunday it restored a photo featuring President Donald Trump to its latest release of Jeffrey Epstein–related documents after a review determined the image did not depict any Epstein victims.

In a post on X, the DOJ said the photo was initially taken down ‘out of an abundance of caution’ after the Southern District of New York flagged it for additional review to protect potential victims.

Following a review, officials concluded no Epstein victims were shown in the photograph, and it was reposted without ‘alteration or redaction,’ according to the DOJ.

‘The Southern District of New York flagged an image of President Trump for potential further action to protect victims,’ the DOJ wrote. ‘Out of an abundance of caution, the Department of Justice temporarily removed the image for further review. After the review, it was determined there is no evidence that any Epstein victims are depicted in the photograph, and it has been reposted without any alteration or redaction.’

Earlier Sunday, Deputy Attorney General Todd Blanche said the removal of the photo had ‘nothing to do with President Trump’ and was instead driven by concerns for the women depicted, he said during an appearance on NBC’s ‘Meet the Press.’

The explanation came after reports that at least 16 files had disappeared from the DOJ’s Epstein-related public webpage less than a day after they were posted on Friday, without public notice or an initial explanation, The Associated Press reported.

The missing files included one that showed a series of photos displayed on a cabinet and inside a drawer. In the drawer, there was a photo of Donald Trump pictured alongside Melania Trump, Epstein and Ghislaine Maxwell, AP reported.

On Saturday, Democrats on the House Oversight Committee criticized the removal of the photo, writing, ‘We need transparency for the American public.’

‘This photo, file 468, from the Epstein files that includes Donald Trump has apparently now been removed from the DOJ release,’ Democrats on the House Oversight Committee posted on X. ‘[Attorney General Pam Bondi] is this true? What else is being covered up? We need transparency for the American public.’

The DOJ released the trove of files after The Epstein Files Transparency Act, signed by President Trump on Nov. 19, 2025, required AG Pam Bondi to release all unclassified records, communications and investigative materials related to Epstein within 30 days.

The agency posted thousands of pages on a government website Friday related to Epstein’s and Maxwell’s sex-trafficking cases. The files were released as the result of a deadline imposed by the Epstein Files Transparency Act.

Fox News Digital’s Lori Bashian contributed to this report.

This post appeared first on FOX NEWS

Sun Summit Minerals Corp. (TSXV: SMN,OTC:SMREF) (OTCQB: SMREF) (‘Sun Summit’ or the ‘Company’) is pleased to announce that it will be attending and presenting at the 51st Annual New Orleans Investment Conference, taking place November 2–5, 2025 at the Hilton New Orleans Riverside.

Niel Marotta, CEO and Director, will host a Sunrise Session presentation on Tuesday, November 4 at 7:15 AM (Churchill B2), where he will share updates on the Company’s flagship JD Project in British Columbia’s Toodoggone District, following the completion of a successful 2025 exploration season.

Space is limited. Investors are invited to RSVP by October 31 to info@sunsummitminerals.com, and to visit Sun Summit at Booth #229 throughout the conference.

The New Orleans Investment Conference brings together leading analysts, newsletter writers, and investors to discuss emerging opportunities across all major asset classes. Register today at https://neworleansconference.com/online-registration/.

About the JD Project

The JD Project is located in the Toodoggone mining district in north-central British Columbia, a highly prospective deposit-rich mineral trend. The project covers an area of over 15,000 hectares and is in close proximity to active exploration and development projects, such as Thesis Gold’s Lawyers and Ranch projects, TDG Gold’s Baker-Shasta projects, Amarc Resource’s AuRORA project, Centerra’s Gold’s Kemess East and Underground projects, as well as the past-producing Kemess open pit copper-gold mine.

The project is 450 kilometres northwest of the city of Prince George, and 25 kilometres north of the Sturdee airstrip. It is proximal to existing infrastructure in place to support the past-producing Kemess mine, including roads and a hydroelectric power line.

The JD Project is in a favourable geological environment characterized by both high-grade epithermal gold and silver mineralization, as well as porphyry-related copper and gold mineralization. Some historical exploration, including drilling, geochemistry and geophysics, has been carried out on the property, however the project area is largely underexplored.

About Sun Summit

Sun Summit Minerals (TSXV: SMN,OTC:SMREF) (OTCQB: SMREF) is a mineral exploration company focused on the discovery, expansion and advancement of district-scale gold and copper assets in British Columbia. The Company’s diverse portfolio includes its flagship JD Project and the nearby Theory Project in the Toodoggone region of north-central B.C., as well as the Buck Project in central B.C.

Further details are available at www.sunsummitminerals.com.

On behalf of the board of directors

Niel Marotta
Chief Executive Officer & Director
info@sunsummitminerals.com

For further information, contact:

Matthew Benedetto, Simone Capital
mbenedetto@simonecapital.ca
Tel. 416-817-1226

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Statements contained in this news release that are not historical in nature may be ‘forward-looking information’ within the meaning of applicable Canadian securities legislation (‘forward-looking statements ‘), which involve risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements, by their nature, require Sun Summit to make certain assumptions and necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements. Forward-looking statements are not guarantees of performance. Words such as ‘may’, ‘will’, ‘would’, ‘could’, ‘expect’, ‘believe’, ‘plan’, ‘anticipate’, ‘intend’, ‘estimate’, ‘continue’, ‘objective’, ‘strategy’, or the negative or comparable terminology, as well as terms usually used in the future and the conditional, are intended to identify forward-looking statements. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including the assumptions, qualifications, limitations or statements relating to the pending results of the drill holes, the success of the exploration program, the impressive results of the drill campaign, the ability of exploration activities (including drilling) to accurately predict mineralization, future drill programs and high-priority targets, our timing and ability to receive assay results, the reliability of historical information that cannot be independently verified by Sun Summit, interests in the JD Project, errors in geological modelling, and the adjacent properties having any significance to the projects in which Sun Summit has an interest. There is significant risk that the forward-looking statements will not prove to be accurate, that the management’s assumptions may not be correct and that actual results may differ materially from such forward-looking statements. These forward-looking statements are based on a number of assumptions which may prove to be incorrect which, without limiting the generality of the following, include: the Company’s ability to obtain assay results for the completed drill program; the anticipated results varying from current indications, including the already released drill results; risks inherent in exploration activities; volatility and sensitivity to market prices; volatility and sensitivity to capital market fluctuations; and fluctuations in metal prices. Accordingly, readers should not place undue reliance on the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof or the dates specifically referenced in this news release, where applicable. Except as required by applicable securities laws and regulation, Sun Summit disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271649

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

Republicans from the House Oversight Committee released a report outlining what they allege are conflicts of interest, financial mismanagement and oversight failures associated with a Biden-era green energy grant program that sent $20 billion to just 8 different nonprofits.

The money stems from the Inflation Reduction Act of 2022, which budgeted roughly $27 billion to advance clean energy and ‘environmental justice’ under the Greenhouse Gas Reduction Fund (GGRF). An undercover recording of a former Biden Environmental Protection Agency (EPA) political appointee, who described disbursements made through GGRF as akin to tossing gold bars off the Titanic at the end of Biden’s term, was cited by EPA Administrator Lee Zeldin in February when he announced that the agency would be looking into the matter. Republicans are currently trying to claw back the funds, which they claim were rushed out the door at the end of the Biden administration with little oversight and steered toward Democratic allies. 

‘Today’s report from the House Oversight Committee exposes the Biden administration’s sweeping green energy scheme, designed to funnel tens of billions in taxpayer dollars to enrich Democratic allies and fund partisan, politically motivated projects,’ House Republican Oversight Chairman James Comer told Fox News Digital. ‘Americans deserve better than this green energy scam disguised as environmental justice, and Oversight Republicans will continue to hold the Biden administration accountable to ensure the EPA operates as intended and that taxpayer dollars are spent transparently, responsibly, and in the best interest of the American people.’

The EPA terminated most of these grants after the Trump administration took office, but the move was met with legal pushback from Democrats. However, last week, a federal appeals court judge struck down a lower court’s ruling that blocked the Trump administration’s move to freeze the funds, arguing the administration was acting in accordance with its role to provide ‘proper oversight’ of how funds are distributed.

The EPA has referred the matter to the agency’s inspector general. The Justice Department and Federal Bureau of Investigation are also running concurrent investigations, the EPA has indicated. However, up to this point, no criminal wrongdoing has been uncovered.   

Oversight and Investigations Subcommittee Ranking Member Rep. Yvette Clarke, D-N.Y., declined to comment on the matter. Additionally, several other top ranking Democrats, including the ranking member on the House Oversight Committee, Rep. Robert Garcia, D-Calif., did not respond to requests for comment.

However, in an Aug. 11 letter to Zeldin signed by several ranking Democrats, including Clarke, they accused Zeldin of ‘lying’ about the Inflation Reduction Act funding. 

‘Time and again, you have boasted about the unlawful activities EPA is conducting under your leadership without any credible evidence to justify your actions,’ the letter stated.

While there may not be any criminal wrongdoing alleged thus far, the picture painted by the investigation by House Oversight Republicans shows the Biden administration ‘turned the Environmental Protection Agency into a vehicle for rewarding political allies, all while risking the stability of our energy infrastructure,’ according to Comer.

‘Today’s report from the House Oversight Committee exposes the Biden administration’s sweeping green energy scheme, designed to funnel tens of billions in taxpayer dollars to enrich Democratic allies and fund partisan, politically motivated projects,’ Comer added.

The report released by Oversight Republicans details how committee staff reviewed ‘tens of thousands’ of documents produced by the GGRF awardees in question. The documents also included EPA materials for reviewing and awarding the GGRF funds, among other records.

The report shows how the EPA judged the applicants using a scoring system that awarded points for different parts of the nonprofits’ proposals. For example, flawless ‘financial risk management’ awarded a total of 85 points, while flawless ‘legal and compliance risk management’ could provide an applicant up to 40 possible points. Meanwhile, the EPA weighted ‘equity and environmental justice’ the same way it did ‘financial statements’ and more than it weighted good ‘governance’ or ‘legal and compliance risk management,’ among other categories. 

‘By doing so, the EPA all but ensured that the grants would go to President Biden’s political allies. All awardees of the GGRF had ‘climate equity’ or diversity, equity, and inclusion (DEI) policies in place or committed to putting equivalent policies in place,’ the House Oversight report argues. ‘EPA criticized multiple applicants because their targeted reductions in emissions were too low. In other cases, the EPA staff complained that there was not enough ‘environmental justice’ expertise represented in leadership or on the boards of the nonprofits. The Biden EPA insisted on climate equity metrics over merit.’

 

After receiving their scores, the program provided a ‘reconciliation process’ for EPA staff to discuss their assessments and adjust their scores, according to the Oversight report. The ultimate decision was then passed to a single ‘selection official’ who made the final determination.

The report also claims that the disbursement review process was ‘full of contradictions.’ It says documents showed EPA officials had concerns about the groups receiving the funds related to overly optimistic projections for financial benefits or emissions reductions, lack of access to private capital, high uninsured cash balances, and lack of transparency. Simultaneously, in other documents, the EPA justified the GGRF recipients as entities ‘with track records, staff, risk management policies, and other programmatic capabilities,’ according to the House Oversight report.

One of the groups under scrutiny, Climate United Fund, was established for the purpose of utilizing the GGRF, according to the Oversight report. The report points to claims from EPA staff indicating the group is ‘a new-entity purpose built for the execution of our program plan and does not have a robust reporting history.’

Climate United, reported just $95,557 in assets for fiscal year 2023 but received $6.97 billion from the EPA, representing a 7,293,980% increase in reported assets since 2023, the Oversight report points out.

Other groups also saw similarly significant increases.

Power Forward Communities received $2 billion as part of the GGRF disbursements. The group, not established until after the Biden administration announced the GGRF application process, reported just $100 in assets in its first and only tax filing – meaning that following the $2 billion GGRF award, the entities’ assets increased 2,000,000,000%, according to the House Oversight report.

‘These tired allegations distract from the fact that EPA’s illegal funding freeze will drive up energy costs for hardworking Americans across the country. When household bills are skyrocketing, Congress should be focused on deploying cheap, clean energy technologies rather than resurfacing false claims,’ Brooke Durham, a spokesperson for Climate United told Fox News Digital when reached for comment. ‘Climate United welcomes the opportunity to explain our work and the benefits of the NCIF program to Congress, federal agencies, and to the public.’

The spokesperson also noted that while the Climate United coalition – which is made up of three separate organizations – is new, the organizations that make it up are not.

‘The organizations that make up Climate United have been investing in communities for over 30 years, and are experts in the capital markets who have collectively managed more than $30 billion in institutional and public funds,’ Durham said. She added that the group was proud to tout a 946.5 point evaluation score by the EPA out of a possible 1050 points, which Durham noted was among the highest of all the awardees.

Power Forward declined to comment. However, the group’s CEO, Tim Mayopolous told CBS News last month that the GGRF award process ‘was a highly structured, competitive process that the United States government went through.’

‘The organizations that are part of our coalition that actually do this work – they have been around collectively for nearly a century, and they have invested or disbursed over $100 billion of capital into communities all over America over those years,’ Mayopolous added. ‘We’re not inexperienced people.’    

Climate United, along with some of the other groups in question, are also under fire for allegedly inflating their executives’ salaries and travel benefits in proposed budgets. The CEO’s salary at Climate United was slated to be over $500,000, and at Power Forward $800,000, with an increase to over $900,00 in a year. One group produced a budget that paid its executive staff of seven employees a total of $24,862,419 over three years, according to the report.

Meanwhile, conflicts of interest, which Zeldin has described as ‘blatant,’ were also laid bare in the report. The director of the GGRF selected by the Biden White House was a former policy director at the group that wanted to pay their executive staffers close to a combined $25 million over three years, according to the report. The report says the director had to recuse himself from the award process because of the conflict.   

At Climate United, the group currently staffs a former Biden climate advisor who worked during the last two years of the former president’s term. Their board makeup while pursuing the GGRF award also had ties to the Obama administration. However, Durham contested the implication that there were conflicts of interest, telling Fox News Digital that no staff or board members at Climate United helped with the design of the program, or the selection of the award recipients.

Power Forward’s GGRF application process was also accused of being led by Democrat allies in the Republican Oversight report. Power Forward was founded by executives at nonprofit Rewiring America, co-founded by top Obama administration advisors, the report states. It also claims that Power Forward had planned on awarding Rewiring America with nearly $500,000,000.

‘The nonprofits receiving awards are littered with connections to Biden Administration staff and allies. The executives and board members at some of the GGRF’s awardees even helped write the policies that created the GGRF and are now benefitting from exorbitant salaries provided by taxpayers,’ the House Oversight report states. 

‘The GGRF was a huge step for the Left in realizing the Green New Deal. The program is a National Green Bank that will flood the economy with billions in taxpayer dollars to fund partisan projects regardless of whether they merit investment or not.’

This post appeared first on FOX NEWS

Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies.

Read on to learn what’s been driving these Canadian biotech firms.

1. Eupraxia Pharmaceuticals (TSX:EPRX)

Year-on-year gain: 141.23 percent
Market cap: C$410.85 million
Share price: C$8.25

Eupraxia Pharmaceuticals is developing clinical candidates that employ its DiffuSphere technology, which delivers treatments to the targeted tissues.

The company’s candidates are currently EP-104GI for eosinophilic esophagitis and EP-104IAR for knee osteoarthritis, and it is exploring the use of its technology for other active compounds as well.

Eupraxia added EP-104GI to its pipeline through its acquisition of EpiPharma Therapeutics in late 2023. The company has continued to advance the treatment through clinical trials in 2025 and released multiple rounds of positive data from its Phase 1b/2a trial cohorts.

In July, Eupraxia dosed its first patient after advancing its investigation to Phase 2b trials based on safety and efficacy data from the earlier Phase 2a patient cohorts. Top-line results from the Phase 2b study are anticipated in the second half of 2026.

In September, the company shared data from the highest-dose cohort of the still ongoing Phase 1b/2a trials, reporting that the group saw the largest improvements so far.

2. Bright Minds Biosciences (CSE:DRUG)

Year-on-year gain: 103.17 percent
Market cap: C$683.67 million
Share price: C$92.95

Bright Minds Biosciences is developing novel serotonin agonists targeting neurocircuit abnormalities linked to neuropsychiatric disorders and epilepsy, designing next-generation treatments that aim to retain the therapeutic benefits of psychedelics while minimizing side effects.

Its lead candidate, BMB-101, a selective 5-HT2C receptor agonist, has shown encouraging preclinical efficacy by stopping seizures in an epilepsy mouse model, evaluated jointly with Firefly Neuroscience (NASDAQ:AIFF).

The company’s stock surged nearly 1,500 percent in October 2024 following H. Lundbeck’s acquisition announcement of a competitor focused on similar targets. Strengthening its epilepsy expertise, Bright Minds expanded its scientific advisory board in early 2025 by adding five leaders in the field.

Ongoing clinical progress and strategic growth initiatives position Bright Minds as a promising contender in the neuropsychiatric treatment landscape.

3. Hemostemix (TSXV:HEM)

Year-on-year gain: 31.25 percent
Market cap: C$18.40 million
Share price: C$0.11

Hemostemix is a clinical-stage biotech company focused on developing autologous stem cell therapies, meaning the treatments use a patient’s own cells to theoretically enhance safety and efficacy.

Its main product, ACP-01, is an autologous cell therapy designed to promote tissue repair and regeneration in areas affected by diseases, including a range of heart diseases.

The company announced its first advanced sales orders for ACP-01 in Q1 2025 and has been working to expand internationally and attract new investment.

Hemostemix secured the regulatory green light for commercial sales in Florida after the state passed Senate Bill 1768. The bill creates a framework in which healthcare providers can administer stem cell therapies that had not yet been approved by the US Food and Drug Administration (FDA) but meet the bill’s guidelines.

The company now offers commercial ACP-01 treatments for ischemic pain in the state under the name VesCell, with sales forecasted to reach C$22.5 million in 2026. Operational plans target cash flow positivity by Q4 2026, supported by a growing physician network and commercial pipeline.

Additionally, Hemostemix is currently collaborating with Firefly Neuroscience on a Phase 1 clinical trial of ACP-01 for vascular dementia.

4. NervGen (TSXV:NGEN)

Year-on-year gain: 79.92 percent
Market cap: C$300.97 million
Share price: C$4.39

NervGen is a clinical-stage Canadian biotechnology company that focuses on developing innovative treatments to enable the nervous system to repair itself following damage from injury or disease.

The company’s core technology targets a mechanism that hinders nervous system repair. When the nervous system is damaged, chondroitin sulfate proteoglycans (CSPG) form a “scar.” Initially, CSPGs help contain damage, but their long-term interaction with the PTPσ receptor inhibits repair.

NervGen’s lead drug candidate, NVG-291, is designed to relieve these inhibitory effects to promote nervous system repair. It received fast-track designation from the US FDA.

NervGen is advancing NVG-291 in a Phase 1b/2a clinical trial for spinal cord injury (SCI) and reported positive data from the chronic cohort in June.

NVG-300, a newer preclinical candidate, is being evaluated for ischemic stroke and SCI.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

The federal trial of Ryan Routh, the accused would-be assassin of President Donald Trump at his West Palm Beach golf club last year, is scheduled to begin Thursday. 

After several rounds of jury selection that began Monday, a panel of 12 jurors — along with four alternates — were seated Wednesday. The group includes six White women, four White men, one Black woman and one Black man. The alternates consist of two White women and two White men.

Opening arguments are scheduled for Thursday at the federal courthouse in Fort Pierce, Florida, where prosecutors are expected to move swiftly into presenting their case.

Roughly 180 people were summoned for jury duty in three waves of 60. Both prosecutors and Routh, who has declined public defense and has chosen to self-represent, questioned candidates to determine whether they could serve impartially.

Routh peppered prospective jurors with offbeat questions, asking about Ukraine, the war in Gaza and even what they would do if a turtle crossed the road while they were driving.

The most recent high-profile federal defendant to represent themselves was Dylann Storm Roof, the mass murderer responsible for the 2015 Charleston, South Carolina, church shooting. Roof briefly represented himself in the federal death penalty phase of his trial in 2016. He requested to proceed pro se and was allowed to do so for part of the proceedings before ultimately reverting to court-appointed counsel.

By the end of Tuesday, the court had already dismissed more than 70 of the initial 180 prospective jurors, many citing strong opinions about Trump, connections to law enforcement or concerns about impartiality in a highly politicized case. 

Routh has pleaded not guilty to federal charges of attempting to assassinate a major presidential candidate and assaulting a federal officer. Prosecutors say he was armed with an AK-style rifle when Secret Service agents stopped him near Trump’s golf course in West Palm Beach in September 2024. The attempt came just months after Trump was shot and narrowly survived an assassination attempt in Butler, Pa.

The trial is expected to last two to four weeks with Trump-appointed Judge Aileen Cannon at the helm of the trial.

Fox News Digital’s Diana Stancy contributed to this report.

This post appeared first on FOX NEWS

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./

Quimbaya Gold Inc. (‘Quimbaya’ or the ‘Company’) (CSE: QIM,OTC:QIMGF) (OTCQB: QIMGF) (FSE: K05) is pleased to announce that it has entered into an agreement with Stifel Canada to act as sole underwriter and bookrunner (the ‘Underwriter’), in connection with a ‘bought deal’ private placement of 14,300,000 units of the Company  (the ‘LIFE Units’) at a price of C$0.70 per LIFE Unit (the ‘Offering Price’) for aggregate gross proceeds of C$10,010,000 (the ‘Offering’), with the LIFE Units to be issued pursuant to the Listed Issuer Financing Exemption (as defined below). 

The Company has granted to the Underwriter an option, exercisable up to 48 hours prior to the closing date, to purchase for resale up to an additional 15% of LIFE Units at the Offering Price for additional gross proceeds of up to C$1,501,500

Each LIFE Unit will consist of one common share (a ‘Common Share‘) and one-half (½) of one Common Share purchase warrant (each whole warrant, a ‘Warrant‘) of the Company. Each Warrant will be exercisable to acquire one Common Share for a period of 36 months following the closing date of the Offering at an exercise price of C$1.00 per common share.

The net proceeds from the Offering are expected to be used to advance the Company’s exploration programs, including drilling at the Tahami South project and follow-up work on regional copper-gold and gold targets, as well as for general working capital.

Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (‘NI 45-106‘), the LIFE Units will be offered for sale to purchasers resident in Canada other than Quebec and/or other qualifying jurisdictions pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the ‘Listed Issuer Financing Exemption‘). Because the Offering is being completed pursuant to the Listed Issuer Financing Exemption, the LIFE Units issued pursuant to the Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. There is an offering document related to the Offering that can be accessed under the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and on the Company’s website at quimbayagold.com. Prospective investors should read the offering document before making an investment decision.

The Offering is scheduled to close on or about November 4, 2025 (the ‘Closing Date‘) and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals including the acceptance of the Canadian Securities Exchange.

The securities referred to in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, ‘U.S. Persons’ (as such term is defined in Regulation S under the U.S. Securities Act) absent such registration or an applicable exemption from the registration requirements of the U.S. Securities Act. This news release does not constitute an offer for sale of securities for sale, nor a solicitation for offers to buy any securities. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.

About Quimbaya 

Quimbaya aims to discover gold resources through exploration and acquisition of mining properties in the prolific gold mining districts of Colombia. Managed by an experienced team in the mining sector, Quimbaya is focused on three projects in the regions of Segovia (Tahami Project), Puerto Berrio (Berrio Project), and Abejorral (Maitamac Project), all located in Antioquia Province, Colombia.

Quimbaya Gold Inc.

Follow on X @quimbayagoldinc
Follow on LinkedIn @quimbayagold
Follow on YouTube @quimbayagoldinc
Follow on Instagram @quimbayagoldinc
Follow on Facebook @quimbayagoldinc

Cautionary Statements

Certain statements contained in this press release constitute ‘forward-looking information’ as that term is defined in applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. Generally, but not always, forward-looking statements and information can be identified by the use of forward-looking terminology such as ‘intends’, ‘expects’ or ‘anticipates’, or variations of such words and phrases or statements that certain actions, events or results ‘may’, ‘could’, ‘should’, ‘would’ or ‘occur’. Forward-looking statements herein include statements and information regarding the closing of the Offering, Offering’s intended use of proceeds, any exercise of Warrants, the future plans for the Company, including any expectations of growth or market momentum, future expectations for the gold sector generally, the Colombian gold sector more particularly, or how global or local market trends may affect the Company, intended exploration on any of the Company’s properties and any results thereof, the strength of the Company’s mineral property portfolio, the potential discovery and potential size of the discovery of minerals on any property of the Company’s, including Tahami South, the aims and goals of the Company, and other forward-looking information. Forward-looking information by its nature is based on assumptions and involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Quimbaya to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. These assumptions include, but are not limited to, that the Company’s exploration and other activities will proceed as expected. The future outcomes that relate to forward-looking statements may be influenced by many factors, including but not limited to: future planned development and other activities on the Company’s mineral properties; an inability to finance the Company; obtaining required permitting on the Company’s mineral properties in a timely manner; any adverse changes to the planned operations of the Company’s mineral properties; failure by the Company for any reason to undertake expected exploration programs; achieving and maintaining favourable relationships with local communities; mineral exploration results that are poorer or better than expected; prices for gold remaining as expected; currency exchange rates remaining as expected; availability of funds for the Company’s projects; prices for energy inputs, labour, materials, supplies and services (including transportation); no labour-related disruptions; no unplanned delays or interruptions in scheduled construction and production; all necessary permits, licenses and regulatory approvals are received in a timely manner; the Offering proceeds being received as anticipated; all requisite regulatory and stock exchange approvals for the Offering are obtained in a timely fashion; investor participation in the Offering; and the Company’s ability to comply with environmental, health and safety laws. Although Quimbaya’s management believes that the assumptions made and the expectations represented by such information are reasonable, there can be no assurance that the forward-looking information will prove to be accurate. Furthermore, should one or more of the risks, uncertainties or other factors materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements or information. Readers are cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of Quimbaya as of the date of this news release and, accordingly, is subject to change after such date. Except as required by law, Quimbaya does not expect to update forward-looking statements and information continually as conditions change.

SOURCE Quimbaya Gold Inc.

View original content: http://www.newswire.ca/en/releases/archive/October2025/23/c7762.html

News Provided by Canada Newswire via QuoteMedia

This post appeared first on investingnews.com